Start Date
January 30, 2015
Primary Completion Date
August 29, 2016
Study Completion Date
August 29, 2016
Sodium thiosulfate
Additional treatment(s) due to lesion progression When intervention occurs, the date of the intervening event should be recorded in the source documents and the (CRF). The subject should continue in the study as scheduled.
Placebo
Additional treatment(s) due to lesion progression When intervention occurs, the date of the intervening event should be recorded in the source documents and the (CRF). The subject should continue in the study as scheduled.
A.A. Northeast Clinical Research Center, Bethlehem
Nephrology Consultants, Huntsville
Nephrology Association of Northern Indiana, Fort Wayne
Lead Sponsor
American Regent, Inc.
INDUSTRY